Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials: Analysis of RTOG 9811 and RTOG 0529

Kharofa, J. R., Yothers, G., Kachnic, L. A., Ajani, J., Meyer, J. E., Augspurger, M. E., Okawara, G. S., Garg, M. K., Schefter, T. E., Swanson, T. A., Doncals, D. E., Kim, H., Zaki, B. I., Narayan, S., Lee, R. J., Mamon, H. J., Schwartz, M. A., Moughan, J., & Crane, C. H. (2022). Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials. American Journal of Clinical Oncology, 45(12), 534–536. https://doi.org/10.1097/coc.0000000000000955
Authors:
Jordan R Kharofa
Greg Yothers
Lisa A Kachnic
Jaffer Ajani
Joshua E Meyer
Mark E Augspurger
Gordon S Okawara
Madhur K Garg
Tracey E Schefter
Todd A Swanson
Desiree E Doncals
Hyun Kim
Bassem I Zaki
Samir Narayan
R Jeffery Lee
Harvey J Mamon
Michael A Schwartz
Jennifer Moughan
Christopher H Crane
Affiliated Authors:
Lisa A Kachnic
Author Keywords:
anal cancer
toxicity index
intensity modulated radiation therapy
Publication Type:
Article
Unique ID:
10.1097/coc.0000000000000955
PMID:
Publication Date:
Data Source:
PubMed

Record Created: